Pragmatic applications of implementation science frameworks to regulatory science: an assessment of FDA Risk Evaluation and Mitigation Strategies (REMS) (2014-2018)
Abstract Background A Risk Evaluation and Mitigation Strategy (REMS) is a drug safety program for certain medications with serious safety concerns required by the U.S. Food and Drug Administration (FDA) of manufacturers to implement to help ensure the benefits of the medication outweigh its risks. F...
Saved in:
Main Authors: | Linda Huynh (Author), Gita A. Toyserkani (Author), Elaine H. Morrato (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adaptation for Regulatory Application: A Content Analysis of FDA Risk Evaluation and Mitigation Strategies Assessment Plans (2014-2018) Using RE-AIM
by: Gita A. Toyserkani, et al.
Published: (2020) -
Application of implementation science framework to develop and adopt regulatory science in different national regulatory authorities
by: Junnan Shi, et al.
Published: (2023) -
The FDA's Regulatory Framework for Chimeric Antigen Receptor‐T Cell Therapies
by: Peter Marks
Published: (2019) -
Adherence to risk evaluation and mitigation strategies (REMS) requirements for monthly testing of liver function
by: Christopher M Blanchette, et al.
Published: (2015) -
Regulatory Science Symposium
Published: (2017)